| EORTC consensus recommendations for the treatment ofmycosis fungoides/Sézary syndrome [50]
|
2006 |
|
43 |
50 |
|
| Towards a pan-European consensus on the treatment ofpatients with colorectal liver metastases. [51]
|
2006 |
|
41 |
38 |
|
| Consensus conference: Implementing treatmentrecommendations on yttrium-90 immunotherapy inclinical practice – Report of a European workshop [52]
|
2008 |
✓ |
27 |
42 |
✓ |
| Diagnosis and treatment of melanoma: Europeanconsensus-based interdisciplinary guideline [53]
|
2010 |
|
39 |
38 |
|
| Breast cancer in pregnancy: Recommendations of aninternational consensus meeting. [54]
|
2010 |
|
49 |
21 |
|
|
Consensus Statements pre IOM 2011 (n = 8), Mean (95% Confidence Interval)
|
40 (33, 47)
|
38 (29, 47)
|
|
| Consensus on Lung Cancer, new clinical recommendationsand current status of biomarker assessment – First-line therapy. [55]
|
2011 |
|
15 |
38 |
|
| Highlights of the EORTC St. Gallen International ExpertConsensus on the primary therapy of gastric,gastroesophageal and oesophageal cancer – Differentialtreatment strategies for subtypes of earlygastroesophageal cancer. [56]
|
2012 |
✓ |
28 |
63 |
|
| Diagnosis and treatment of melanoma. Europeanconsensus-based interdisciplinary guideline – Update 2012 [57]
|
2012 |
|
35 |
63 |
|
| German, Austrian and Swiss consensus conference on thediagnosis and local treatment of the axilla in breast cancer [58]
|
2013 |
|
50 |
46 |
|
|
Consensus Statements post IOM 2011 (n = 4), Mean (95% Confidence Interval)
|
32 (18, 46)
|
53 (40, 65)
|
|
|
Clinical Practice Guidelines
|
| Guidelines for surgical treatment of hepatoblastoma in themodern era–recommendations from the Childhood Liver Tumour Strategy Group of the International Society ofPaediatric Oncology (SIOPEL) [59]
|
2005 |
|
21 |
46 |
|
| Malignant ascites: systematic review and guideline for treatment. [60]
|
2006 |
|
63 |
46 |
|
| EORTC guidelines for the use of granulocyte-colonystimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adultpatients with lymphomas and solid tumours. [61]
|
2006 |
✓ |
72 |
50 |
|
| EORTC guidelines for the use of erythropoietic proteins inanaemic patients with cancer: 2006 update [62]
|
2007 |
✓ |
60 |
88 |
|
| Tumour markers in colorectal cancer: European Group onTumour Markers (EGTM) guidelines for clinical use [63]
|
2007 |
|
38 |
64 |
|
| Guidelines on the standards for the training of specialisedhealth professionals dealing with breast cancer [64]
|
2007 |
✓ |
0 |
46 |
|
| Guidelines for the assessment of oral mucositis in adultchemotherapy, radiotherapy and haematopoietic stem cell transplant patients. European journal of cancer [65]
|
2008 |
|
69 |
58 |
|
| Diagnosis and antimicrobial therapy of lung infiltrates infebrile neutropenic patients: Guidelines of the infectiousdiseases working party of the German Society of Haematology and Oncology. [66]
|
2009 |
|
18 |
58 |
|
| The development of evidence-based guidelines on mouthcare for children, teenagers and young adults treated for cancer [67]
|
2010 |
|
76 |
63 |
|
| 2010 update of EORTC guidelines for the use ofgranulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropeniain adult patients with lymphoproliferative disorders and solid tumours [68]
|
2011 |
✓ |
63 |
50 |
✓ |
| The development of evidence-based Europeanguidelines on the management of depression inpalliative cancer care [69]
|
2011 |
|
41 |
71 |
|
|
Clinical Practice Guidelines pre IOM 2011 (n = 11) Mean (95% Confidence Interval)
|
47 (32, 62)
|
58 (51, 66)
|
|
| Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines. European journal of cancer[70]
|
2011 |
|
28 |
75 |
|
| EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma [71]
|
2012 |
|
49 |
58 |
|
|
Clinical Practice Guidelines post IOM 2011 (n = 2) Mean (95% Confidence Interval)
|
39 (18, 59)
|
67 (50, 83)
|
|
